Skip to main content

Table 4 Frequency of use of specific medications included in ‘Other’ category for LOT1-LOT3

From: A retrospective cohort study of treatment patterns among patients with metastatic soft tissue sarcoma in the US

 

Frequency

Percent (%)

LOT 1 regimen

 Carboplatin, paclitaxel

29

5.2

 Paclitaxel

28

5.0

 Carboplatin

18

3.2

 Temozolomide

14

2.5

 Bevacizumab

12

2.2

 Cyclophosphamide, doxorubicin, vincristine

9

1.6

 Sunitinib

8

1.4

 Docetaxel

8

1.4

 Etoposide

7

1.3

 Ifosfamide

7

1.3

 Etoposide, ifosfamide

6

1.1

 Carboplatin, docetaxel

6

1.1

 Irinotecan, temozolomide

5

0.9

 Sorafenib

5

0.9

 Gemcitabine, paclitaxel

4

0.7

 Carboplatin, etoposide

4

0.7

 Cyclophosphamide

4

0.7

 Dacarbazine

4

0.7

 Docetaxel, doxorubicin, gemcitabine

4

0.7

 Bevacizumab, temozolomide

3

0.5

 Bevacizumab, carboplatin, paclitaxel

3

0.5

 Vincristine

3

0.5

 Vinorelbine

3

0.5

 Carboplatin, gemcitabine

3

0.5

 Cyclophosphamide, dactinomycin, vincristine

3

0.5

 Cyclophosphamide, doxorubicin, etoposide, ifosfamide, vincristine

3

0.5

 Dacarbazine, doxorubicin

3

0.5

 Eribulin

3

0.5

 Gemcitabine, vinorelbine

2

0.4

 Irinotecan

2

0.4

 Irinotecan, temozolomide, vincristine

2

0.4

 Carboplatin, irinotecan

2

0.4

 Cyclophosphamide, etoposide

2

0.4

 Cyclophosphamide, vinorelbine

2

0.4

 Cyclophosphamide, dacarbazine, doxorubicin

2

0.4

 Cyclophosphamide, doxorubicin, irinotecan, vincristine

2

0.4

 Docetaxel, gemcitabine, pazopanib

2

0.4

 Doxorubicin, gemcitabine

2

0.4

 Doxorubicin, pazopanib

2

0.4

 Etoposide, ifosfamide, methotrexate

1

0.2

 Gemcitabine, ifosfamide

1

0.2

 Gemcitabine, sunitinib

1

0.2

 Ifosfamide, paclitaxel

1

0.2

 Methotrexate

1

0.2

 Pazopanib, sorafenib

1

0.2

 Bevacizumab, irinotecan

1

0.2

 Bevacizumab, irinotecan, temozolomide, vincristine

1

0.2

 Bevacizumab, paclitaxel

1

0.2

 Bevacizumab, docetaxel

1

0.2

 Bevacizumab, doxorubicin

1

0.2

 Temozolomide, topotecan, vincristine

1

0.2

 Carboplatin, etoposide, irinotecan

1

0.2

 Carboplatin, gemcitabine, paclitaxel

1

0.2

 Carboplatin, methotrexate, paclitaxel

1

0.2

 Carboplatin, epirubicin, paclitaxel

1

0.2

 Cyclophosphamide, dacarbazine, doxorubicin, vincristine

1

0.2

 Cyclophosphamide, doxorubicin

1

0.2

 Cyclophosphamide, doxorubicin, etoposide, vincristine

1

0.2

 Cyclophosphamide, doxorubicin, paclitaxel

1

0.2

 Dacarbazine, gemcitabine

1

0.2

 Dacarbazine, pazopanib

1

0.2

 Dacarbazine, doxorubicin, gemcitabine

1

0.2

 Dacarbazine, doxorubicin, ifosfamide

1

0.2

 Dacarbazine, doxorubicin, methotrexate

1

0.2

 Docetaxel, paclitaxel

1

0.2

 Docetaxel, doxorubicin, gemcitabine, ifosfamide

1

0.2

 Doxorubicin, gemcitabine, vinorelbine

1

0.2

 Doxorubicin, ifosfamide, pazopanib

1

0.2

 Doxorubicin, ifosfamide, vincristine

1

0.2

LOT 2 regimen

 Methotrexate

7

3.1

 Paclitaxel

7

3.1

 Carboplatin, paclitaxel

7

3.1

 Doxorubicin, ifosfamide

5

2.2

 Gemcitabine, paclitaxel

4

1.7

 Ifosfamide

4

1.7

 Sorafenib

4

1.7

 Vinorelbine

4

1.7

 Dacarbazine, doxorubicin

4

1.7

 Docetaxel

4

1.7

 Bevacizumab

3

1.3

 Carboplatin

3

1.3

 Dacarbazine

3

1.3

 Etoposide

2

0.9

 Bevacizumab, paclitaxel

2

0.9

 Bevacizumab, temozolomide

2

0.9

 Bevacizumab, docetaxel, gemcitabine

2

0.9

 Carboplatin, gemcitabine

2

0.9

 Doxorubicin, gemcitabine

2

0.9

 Eribulin

2

0.9

 Etoposide, ifosfamide

1

0.4

 Etoposide, ifosfamide, irinotecan, vincristine

1

0.4

 Gemcitabine, irinotecan

1

0.4

 Gemcitabine, pazopanib

1

0.4

 Gemcitabine, vinorelbine

1

0.4

 Irinotecan, temozolomide

1

0.4

 Irinotecan, temozolomide, vincristine

1

0.4

 Paclitaxel, pazopanib

1

0.4

 Pazopanib, sunitinib

1

0.4

 Sunitinib

1

0.4

 Bevacizumab, dacarbazine

1

0.4

 Bevacizumab, doxorubicin

1

0.4

 Topotecan

1

0.4

 Carboplatin, methotrexate, paclitaxel

1

0.4

 Cyclophosphamide, etoposide

1

0.4

 Cyclophosphamide, methotrexate

1

0.4

 Cyclophosphamide, temozolomide, topotecan

1

0.4

 Cyclophosphamide, topotecan

1

0.4

 Cyclophosphamide, vincristine

1

0.4

 Cyclophosphamide, dacarbazine, doxorubicin

1

0.4

 Cyclophosphamide, dacarbazine, doxorubicin, vincristine

1

0.4

 Cyclophosphamide, docetaxel

1

0.4

 Cyclophosphamide, doxorubicin, etoposide, ifosfamide

1

0.4

 Cyclophosphamide, doxorubicin, etoposide, ifosfamide, vincristine

1

0.4

 Cyclophosphamide, doxorubicin, vincristine

1

0.4

 Dacarbazine, gemcitabine

1

0.4

 Dacarbazine, ifosfamide

1

0.4

 Dacarbazine, doxorubicin, ifosfamide

1

0.4

 Docetaxel, gemcitabine, paclitaxel

1

0.4

 Docetaxel, gemcitabine, pazopanib

1

0.4

 Docetaxel, doxorubicin, gemcitabine

1

0.4

 Doxorubicin, gemcitabine, vinorelbine

1

0.4

 Doxorubicin, paclitaxel

1

0.4

 Doxorubicin, pazopanib

1

0.4

LOT 3 regimen

 Vinorelbine

4

4.5

 Gemcitabine

3

3.4

 Paclitaxel

2

2.3

 Cyclophosphamide, dactinomycin, vincristine

2

2.3

 Cyclophosphamide, doxorubicin, vincristine

2

2.3

 Docetaxel

2

2.3

 Etoposide, ifosfamide

1

1.1

 Etoposide, ifosfamide, irinotecan

1

1.1

 Gemcitabine, irinotecan

1

1.1

 Gemcitabine, methotrexate

1

1.1

 Ifosfamide

1

1.1

 Irinotecan, temozolomide

1

1.1

 Irinotecan, vincristine

1

1.1

 Sorafenib

1

1.1

 Bevacizumab, gemcitabine, paclitaxel

1

1.1

 Bevacizumab, cyclophosphamide, sorafenib

1

1.1

 Carboplatin

1

1.1

 Topotecan

1

1.1

 Cyclophosphamide, topotecan

1

1.1

 Cyclophosphamide, doxorubicin

1

1.1

 Cyclophosphamide, doxorubicin, irinotecan, vincristine

1

1.1

 Dacarbazine

1

1.1

 Dacarbazine, pazopanib

1

1.1

 Dacarbazine, vinorelbine

1

1.1

 Dacarbazine, doxorubicin

1

1.1

Back to article page